Articles by Kevin C. Maki (15)

A Commentary on the implications of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial: Should ezetimibe move to the “Back of the Line” as a therapy for dyslipidemia?

Peter P. Toth and Kevin C. Maki

Journal of Clinical Lipidology 2 ( 5 ): 313 - 317 , 2008

Prescription omega-3 acid ethyl esters plus simvastatin 20 and 80 mg: effects in mixed dyslipidemia

Kevin C. Maki, Barry C. Lubin, Matthew S. Reeves, Mary R. Dicklin and William S. Harris

Journal of Clinical Lipidology 3 ( 1 ): 33 - 38 , 2009

Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women

Kevin C. Maki, Martyn R. Rubin, Les G. Wong, Jamie F. McManus, Christopher D. Jensen, John W. Marshall and Andrea Lawless

Journal of Clinical Lipidology 3 ( 4 ): 289 - 296 , 2009

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia

Michael H. Davidson, Kevin C. Maki, Harold Bays, Roderick Carter and Christie M. Ballantyne

Journal of Clinical Lipidology 3 ( 5 ): 332 - 340 , 2009

Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia

Kevin C. Maki, Dustie N. Butteiger, Tia M. Rains, Andrea Lawless, Matthew S. Reeves, Chuck Schasteen and Elaine S. Krul

Journal of Clinical Lipidology 4 ( 6 ): 531 - 542 , 2010

Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease

Kevin C. Maki, Michael H. Davidson, Mary R. Dicklin, Marjorie Bell, MarySue Witchger and Steven B. Feinstein

Journal of Clinical Lipidology 5 ( 3 ): 141 - 151 , 2011

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Michael H. Davidson, Christie M. Ballantyne, Terry A. Jacobson, Vera A. Bittner, Lynne T. Braun, Alan S. Brown, W. Virgil Brown, William C. Cromwell, Ronald B. Goldberg, James M. McKenney, Alan T. Remaley, Allan D. Sniderman, Peter P. Toth, Sotirios Tsimikas, Paul E. Ziajka, Kevin C. Maki and Mary R. Dicklin

Journal of Clinical Lipidology 5 ( 5 ): 338 - 367 , 2011

Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia

Kevin C. Maki, Harold E. Bays, Mary R. Dicklin, Susan L. Johnson and Mayadah Shabbout

Journal of Clinical Lipidology 5 ( 6 ): 483 - 492 , 2011

Fatty acids in cardiovascular health and disease: A comprehensive update

Seth J. Baum, Penny M. Kris-Etherton, Walter C. Willett, Alice H. Lichtenstein, Lawrence L. Rudel, Kevin C. Maki, Jay Whelan, Christopher E. Ramsden and Robert C. Block

Journal of Clinical Lipidology 6 ( 3 ): 216 - 234 , 2012

A meta-analysis of randomized controlled trials that compare the lipid effects of beef versus poultry and/or fish consumption

Kevin C. Maki, Mary E. Van Elswyk, Dominik D. Alexander, Tia M. Rains, Eugenia L. Sohn and Shalene McNeill

Journal of Clinical Lipidology 6 ( 4 ): 352 - 361 , 2012

Treatment options for the management of hypertriglyceridemia: Strategies based on the best-available evidence

Kevin C. Maki, Harold E. Bays and Mary R. Dicklin

Journal of Clinical Lipidology 6 ( 5 ): 413 - 426 , 2012

Planning a clinical trial

W. Virgil Brown, Harold E. Bays, Kevin C. Maki and Robert A. Wild

Journal of Clinical Lipidology 6 ( 6 ): 484 - 495 , 2012

Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: A subanalysis of the USAGE study

Matthew K. Ito, Kevin C. Maki, Eliot A. Brinton, Jerome D. Cohen and Terry A. Jacobson

Journal of Clinical Lipidology 8 ( 1 ): 69 - 76 , 2014

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

John J.P. Kastelein, Kevin C. Maki, Andrey Susekov, Marat Ezhov, Borge G. Nordestgaard, Ben N. Machielse, Douglas Kling and Michael H. Davidson

Journal of Clinical Lipidology 8 ( 1 ): 94 - 106 , 2014

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - executive summary

Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, Carl E. Orringer, Harold E. Bays, Peter H. Jones, James M. McKenney, Scott M. Grundy, Edward A. Gill, Robert A. Wild, Don P. Wilson and W. Virgil Brown

Journal of Clinical Lipidology 8 ( 5 ): 473 - 488 , 2014